Nymox shareprice bouyed by recent financing success

Nymox Pharmaceutical Corp. {NSDAQ: NYMX} share price has risen sharply since the recently announced financing at 45 cents, and now stands at 66c.

Following their disastrous news release of some months ago where the stock dropped from over $5 to 40 cents, the stock is now showing some green shots of recovery.


It’s encouraging to see the shareprice recovering so soon after a 45c placing, and this augurs well for the future, as the stock is fighting back on no known news.

Clearly a long road ahead, but Nymox are still alive and kicking.

Below is a reminder of the recent news release.


Official news release

Nymox Announces Private Placements of US$400,000

2015-03-20  – News Release

HASBROUCK HEIGHTS, N.J., March 20, 2015– Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today recent private placements of 883,058 shares, with total proceeds of US$400,000. An additional 441,529 warrants exercisable at $2.00 were included in the private placements.

For more information please contact info@nymox.com or 800-936-9669.

This press release contains certain “forward-looking statements” as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. Development of drug products involves substantial risks and actual results may differ materially from expectations. Factors that could cause actual results or events to differ materially from those projected in forward-looking statements are detailed from time to time in Nymox’s filings with the United States Securities and Exchange Commission and other regulatory authorities.

CONTACT: Paul Averback
         Nymox Pharmaceutical Corporation